Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Auddia Announces New $3.5M Financing
-
Nano Labs Announces Second Half of 2023 Financial Results
-
Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024
-
HireVue Joins US Artificial Intelligence Safety Institute Consortium
-
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
-
RevoluGROUP and eSignus: Bridging the Digital Asset Divide Through Revolutionary Integration of Digital and Fiat Payment Fabrics
-
Vislink to Report Full Year and Fourth Quarter 2023 Financial Results on Monday, April 1, 2024, at 8:30 a.m. ET
-
WORKSPORT ANNOUNCES PRICING OF APPROXIMATELY $2.8 MILLION REGISTERED DIRECT OFFERING & CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
-
VoIP-Pal Announces Three New Special Advisor Appointments
-
Sacks Parente Golf, Inc. Announces Year End 2023 Financial Results and Provides Corporate Update
-
Inspired Entertainment Provides Update on Fourth Quarter and Year End Reporting Timeline
-
Inovalon Announces Converged Submissions To Support Health Plan Risk Adjustment Programs
-
Kratos Receives $57.6 Million Contract for 70 BQM-177A Aerial Targets
-
Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects
-
Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma
-
Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
-
Gabelli Funds to Host 10th Annual Waste & Sustainability Symposium Thursday, April 4, 2024
-
Duos Technologies Group Sets Fourth Quarter and Full Year 2023 Earnings Call for Monday, April 1, 2024 at 4:30 PM ET
-
Panostaja's Investment Company Grano Ends Change Negotiations
-
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
-
Change in the holding of WithSecure Corporation's own shares
-
ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator™ VAR 200 in Patients with Diabetic Kidney Disease
-
BY WAY OF YOUR HEART is a Poetic Journey through Romance, Loss, Healing and Joy
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc
-
Timeless Collaboration: McWhorter Family Trust Bestows Patek Philippe with Family Trust Warrant for Timepiece Mastery
-
Man Group PLC : Form 8.3 - UK Commercial Property REIT Limited
-
Man Group PLC : Form 8.3 - Smith (DS) plc
-
American Rare Earths’ Scoping Study confirms low-cost, scalable world-class REE project
-
Major shareholder announcement – BlackRock, Inc.
-
FTI Consulting Expands Transfer Pricing Expertise in the United States with Addition of Cedric Bernardeau
-
SL Green Realty Corp. to Release First Quarter 2024 Financial Results After Market Close on April 17, 2024
-
Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy
-
Eightco announces Paul Vassilakos as Executive Chairman and Chief Executive Officer and Certain Balance Sheet Improvements
-
Titan Announces Merger Agreement with Conavi
-
nCino to Acquire DocFox
-
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
-
Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
-
Zevra Therapeutics to Report 2023 Fourth Quarter and Full Year Financial Results on March 28, 2024
-
DeFi Technologies’ Wholly-Owned Subsidiary Valour Inc., Bitcoin Suisse AG, and STOXX Launch the 1Valour STOXX Bitcoin Suisse Digital Asset Blue Chip ETP
-
Auction result of Treasury Bills - RIKV 24 0619 - RIKV 24 0918
-
BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems
-
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
-
Arch Biopartners Clinical Team Publishes Data from Phase II Trial for LSALT Peptide Targeting Organ Inflammation in Hospitalized Patients Infected with SARS-CoV-2
-
Major shareholder announcement – AIM International Mutual Funds
-
Man Group PLC : Form 8.3 - Mondi plc
-
Major shareholder announcement – Invesco Ltd.
-
VERB's MARKET.live Adds 100 More Retail Brands to its Livestream Social Shopping Platform
-
Acquisition of ISS A/S shares by Member of the Board of Directors
-
SX Network Closes Successful Strategic Funding Round
